A detailed history of Asset Management One Co., Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 68,615 shares of EXAS stock, worth $3.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
68,615
Previous 65,778 4.31%
Holding current value
$3.99 Million
Previous $2.78 Million 68.08%
% of portfolio
0.02%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$42.43 - $70.83 $120,373 - $200,944
2,837 Added 4.31%
68,615 $4.67 Million
Q2 2024

Jul 18, 2024

BUY
$41.33 - $74.26 $73,526 - $132,108
1,779 Added 2.78%
65,778 $2.78 Million
Q1 2024

May 02, 2024

SELL
$56.27 - $73.77 $269,083 - $352,768
-4,782 Reduced 6.95%
63,999 $4.42 Million
Q4 2023

Jan 24, 2024

SELL
$59.06 - $75.72 $85,932 - $110,172
-1,455 Reduced 2.07%
68,781 $5.09 Million
Q3 2023

Oct 19, 2023

BUY
$65.94 - $99.04 $155,024 - $232,843
2,351 Added 3.46%
70,236 $4.79 Million
Q2 2023

Jul 31, 2023

SELL
$62.68 - $95.05 $216,496 - $328,302
-3,454 Reduced 4.84%
67,885 $6.37 Million
Q1 2023

Apr 25, 2023

BUY
$47.19 - $70.77 $108,253 - $162,346
2,294 Added 3.32%
71,339 $4.84 Million
Q4 2022

Feb 06, 2023

SELL
$30.35 - $53.15 $16,540 - $28,966
-545 Reduced 0.78%
69,045 $3.42 Million
Q3 2022

Nov 04, 2022

SELL
$31.97 - $49.37 $20,908 - $32,287
-654 Reduced 0.93%
69,590 $2.26 Million
Q2 2022

Jul 29, 2022

BUY
$35.61 - $76.23 $13,781 - $29,501
387 Added 0.55%
70,244 $2.77 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $103,953 - $149,067
-1,806 Reduced 2.52%
69,857 $4.88 Million
Q4 2021

Feb 09, 2022

SELL
$72.5 - $100.68 $135,502 - $188,170
-1,869 Reduced 2.54%
71,663 $5.21 Million
Q3 2021

Nov 02, 2021

BUY
$90.24 - $124.05 $131,389 - $180,616
1,456 Added 2.02%
73,532 $7.02 Million
Q2 2021

Aug 03, 2021

BUY
$93.66 - $139.27 $30,064 - $44,705
321 Added 0.45%
72,076 $8.96 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $19,000 - $25,266
163 Added 0.23%
71,755 $9.46 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $24,703 - $35,245
248 Added 0.35%
71,592 $9.46 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $1,020 - $1,428
14 Added 0.02%
71,344 $7.27 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $28,432 - $47,302
-510 Reduced 0.71%
71,330 $6.2 Million
Q1 2020

May 14, 2020

SELL
$37.9 - $104.44 $573,843 - $1.58 Million
-15,141 Reduced 17.41%
71,840 $4.17 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $235,465 - $302,411
3,032 Added 3.61%
86,981 $8.04 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $2.2 Million - $2.98 Million
24,324 Added 40.79%
83,949 $7.59 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $5.34 Million - $7.04 Million
59,625 New
59,625 $7.04 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $295,152 - $545,688
-7,800 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $310,596 - $448,734
7,800 New
7,800 $315,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.